| Video
What would the world be like without opioids? Dr. Clark hypothesizes on the implications for patients with pain, and on what the characteristics of a “better” opioid might include.
| Video
In this 2-part segment, Dr. Passik discusses some of the lessons learned during and following the Decade of Pain Control and Research, and implications for the appropriate engagement of opioid therapy in chronic noncancer pain management.
| Video
In this 2-part segment, Dr. Passik discusses some of the lessons learned during and following the Decade of Pain Control and Research, and implications for the appropriate engagement of opioid therapy in chronic noncancer pain management.
| Article
The Iceberg Cometh
Dr. Passik is Director, Clinical Addiction Research and Education, Millenium Laboratories Clinical Education, San Diego, California. He has over 25 years’ experience in clinical practice as a pain psychologist specializing in addiction medicine. He is also a longtime member of...
| Video
A discussion of the evolving medical/administrative/legal landscape that confronts prescribers of opioid medications. Attorney Furman offers additional advice on how clinicians can protect their practices.
| Video
A pharmacist perspective on the pros and cons of opioid treatment agreements.
| Article
The transdermal formulations of fentanyl and buprenorphine are for patients who have chronic pain. An important distinction is, with transdermal fentanyl the patient has to be opioid tolerant, on the equivalent of 60 mg of oral morphine a day for at least a week, whereas with transdermal...
| Article
The common adverse effects of opioid therapy include nausea and vomiting, and, of course, constipation. Sedation, also, although this could be the result of pain-induced sleep deprivation, and now that you’re treating the pain, they’re catching up on their sleep. Generally, that gets better over the...
| Video
Dr. McPherson discusses what the primary care clinician should know about initiating methadone therapy, including an outline of some of the precautions that should be considered with this opioid.
| Video
Dr. McPherson is an acclaimed professor of pharmacy, primary care practitioner and consultant in hospice and palliative care. This segment examines some adverse events that are associated with opioid analgesics.